Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rifaximin-treatment of Collagenous Colitis:

NCT03658993 is registered in ClinicalTrials.gov with Bonderup, Ole K., M.D. as lead sponsor.

NCT NCT03658993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03658993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rifaximin-treatment of Collagenous Colitis:
Lead sponsor
Bonderup, Ole K., M.D.
Phase
Phase 3
Overall status
Unknown status
Start date
November 1, 2018
Completion date
November 1, 2021
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

collagenous colitis